🚚  Free shipping over $140 — Canadian domestic, no customs Skip to content
Back to Blog

How to Reconstitute Peptides: Complete Laboratory Guide

At a Glance

To reconstitute a lyophilized research peptide, bring the vial to room temperature, sanitize the stopper, then slowly inject bacteriostatic water down the inside glass wall — the volume set by the target concentration. Swirl gently until clear (never shake), then label and refrigerate at 2–8°C. Use the reconstitution calculator to find the exact diluent volume and mg/mL.

Required Equipment

  • Lyophilized peptide vial
  • Bacteriostatic water (sterile water preserved with 0.9% benzyl alcohol for multi-use vial stability)
  • Insulin syringes (U-100, 0.5–1 mL) and 3–5 mL syringes for larger volumes
  • Alcohol swabs (70% isopropyl), nitrile gloves, sharps container, labeling pen or tape
  • Low-binding microtubes (if aliquoting for storage)

Reconstitution Steps

  1. Bring vials to room temperature before opening — cold lyophilized cakes dissolve more slowly and can cause condensation issues
  2. Clean work surface; don nitrile gloves
  3. Wipe rubber stoppers on both vials with alcohol swabs; allow to dry completely
  4. Draw bacteriostatic water into syringe (volume calculated based on target concentration)
  5. Insert needle at a shallow angle against the peptide vial wall; inject slowly and let the water run down the glass surface to avoid foaming
  6. Gently swirl the vial — never shake vigorously; agitation causes aggregation and denaturation
  7. Allow 2–5 minutes for full dissolution; some peptides (particularly larger or more hydrophobic sequences) may require up to 10 minutes
  8. Label immediately with peptide name, date reconstituted, volume added, and final concentration; refrigerate at 2–8°C

Concentration Calculation

Formula: Mass (mg) ÷ Volume (mL) = Concentration (mg/mL) — or let the dose calculator run the numbers.

Example: 5 mg peptide + 2 mL BAC water = 2.5 mg/mL (2500 mcg/mL)

U-100 syringe reference: 10 units = 0.10 mL · 25 units = 0.25 mL · 50 units = 0.50 mL · 100 units = 1.00 mL

Practical example for research dosing calculations:

If a rat weighs 300 g and the protocol calls for 10 µg/kg: - Dose needed: 0.3 kg × 10 µg/kg = 3 µg = 0.003 mg - At 2.5 mg/mL concentration: 0.003 mg ÷ 2.5 mg/mL = 0.0012 mL = 1.2 µL - For practical administration, diluting to 0.25 mg/mL enables more measurable volumes

Alternative Diluents

Bacteriostatic water (BAC water) is the standard diluent for multi-dose research vials. The 0.9% benzyl alcohol preservative inhibits microbial growth, extending the reconstituted peptide's refrigerated stability to 28–30 days — diluent quality matters as much as peptide purity. This is the appropriate choice for most research peptides in routine laboratory use.

Sterile water for injection (SWFI) — preservative-free sterile water suitable for single-use preparation. Offers no antimicrobial protection; reconstituted solutions should be used within hours or same-day. Appropriate when benzyl alcohol is contraindicated by assay design (some cell culture applications where benzyl alcohol at trace concentrations interferes with cell viability).

Sterile saline (0.9% NaCl) — isotonic diluent appropriate for some in vivo administration routes. Some peptides are more stable in isotonic solution than in water. Verify compatibility with the specific peptide before use.

Acetic acid (0.1–1% in sterile water) — used for peptides with poor aqueous solubility at neutral pH. Some hydrophobic peptides dissolve more readily in dilute acetic acid. After dissolution, the preparation may then be diluted into buffered saline for a final isotonic solution.

DMSO — used sparingly for highly hydrophobic peptides that fail to dissolve in aqueous diluents. DMSO is cytotoxic at higher concentrations; standard practice limits final DMSO concentration to ≤0.1% in cell assays, which typically requires extensive dilution.

Peptide-Specific Reconstitution Notes

BPC-157: Dissolves readily in BAC water. Both acetate and arginine salt forms reconstitute well. Arginine salt typically shows faster dissolution. Reconstituted solutions are typically clear and colorless.

TB-500: Dissolves in BAC water; may require gentle warming (not exceeding room temperature) and additional swirling time for complete dissolution due to the tetrapeptide's amphiphilic properties.

CJC-1295 (both variants): BAC water is standard. The DAC modification does not materially alter reconstitution behavior. Solutions should be clear; cloudiness indicates aggregation.

Semaglutide and Tirzepatide: These larger fatty-acid-modified peptides can require more careful reconstitution. Add diluent slowly, swirl gently; avoid vigorous agitation. Some researchers use slightly acidic diluents (pH ~4) for initial dissolution, followed by pH adjustment with buffer. Follow supplier-specific guidance when available.

Semax: Available as lyophilized powder and as pre-formulated nasal spray solutions. Lyophilized Semax reconstitutes in BAC water or sterile saline. Intranasal delivery requires appropriate formulation pH (near physiological) for mucosal tolerance.

Troubleshooting

  • Cloudiness after reconstitution: Aggregation or contamination — discard immediately; do not attempt clarification by filtration and proceed with use
  • Undissolved residue: Allow additional rest time (10–15 min) with gentle swirling; if residue persists, check diluent volume and consider alternative diluent; never vortex
  • Foamy solution: Caused by agitation — allow to settle undisturbed for 5–10 minutes; foam resolves as bubbles dissipate; solution integrity is typically unaffected
  • Unexpected color: A faint yellow tint may be acceptable in some peptide preparations but warrants supplier consultation; any brown or precipitate color indicates degradation
  • Difficulty drawing from vial: Ensure needle gauge is appropriate (25–27G typical for U-100 syringes); create a slight vacuum by withdrawing plunger before puncture to ease extraction

Safety and Documentation

Maintain a laboratory log recording: peptide name, batch number, COA reference, reconstitution date, diluent used, volume added, calculated concentration, and storage location (the peptide storage guide covers post-reconstitution handling). This documentation supports research reproducibility and provides batch traceability for institutional compliance purposes. Dispose of needles in approved sharps containers; follow institutional biohazard waste protocols for peptide solutions.

Frequently Asked Questions

What water is used to reconstitute research peptides? Bacteriostatic water — sterile water preserved with 0.9% benzyl alcohol — is the standard diluent for multi-dose research vials. The preservative inhibits microbial growth, extending refrigerated stability to 28–30 days. Sterile water for injection, saline, dilute acetic acid, and DMSO are alternatives used for specific solubility or assay requirements.

How do I calculate peptide concentration after reconstitution? Use the formula: mass (mg) divided by volume (mL) equals concentration (mg/mL). For example, 5 mg of peptide in 2 mL of bacteriostatic water gives 2.5 mg/mL (2500 mcg/mL). On a U-100 syringe, 100 units equals 1.00 mL, so 25 units equals 0.25 mL.

Why should peptides be swirled and not shaken during reconstitution? Inject the diluent slowly against the vial wall and gently swirl — never shake vigorously. Agitation causes foaming, aggregation, and denaturation. Allow 2–5 minutes for full dissolution, or up to 10 minutes for larger or more hydrophobic sequences, then label and refrigerate at 2–8°C.

What should be recorded when reconstituting a peptide? Maintain a laboratory log recording the peptide name, batch number, COA reference, reconstitution date, diluent used, volume added, calculated concentration, and storage location. This documentation supports research reproducibility and provides batch traceability for institutional compliance purposes.

Research Disclaimer

All peptides described in this guide are for in vitro laboratory research use only. Reconstitution protocols described are for laboratory preparation purposes. This content does not constitute medical advice or guidance for human administration.